Torex Gold Reports Positive Results from the 2024 ELG Underground Drilling Program June 27, 2024 6:00 PM EDT | Source: Torex Gold Resources Inc. Toronto, Ontario--(Newsfile Corp. - June 27, 2024) - Torex Gold Resources Inc. (the "Company" or "Torex") (TSX: TXG) announces assay results from the Company's ongoing drilling program at El Limón Guajes ("ELG") Underground. The results to date support Torex's target of extending the mine life of ELG Underground beyond 2028 by identifying new zones of higher-grade ...

Core Insights - 10x Genomics' Xenium In Situ platform was utilized in a study published in the Journal of Dental Research, providing new insights into the cellular mechanisms involved in secondary palate formation [1][2] - The study highlights the role of the Pax9 protein as a transcription factor in Wnt signaling, which is crucial for embryonic development [2][3] Company Overview - 10x Genomics is a leader in single cell and spatial biology, offering integrated solutions that include instruments, consumables, and software to enhance biological research [8][9] - The company's products are instrumental in advancing research across various fields, including oncology, immunology, and neuroscience, contributing to significant breakthroughs in understanding health and disease [9] Research Findings - The study revealed that the Xenium platform allowed for higher spatial resolution in gene expression analysis, enhancing the understanding of signaling pathways in palate development [3][4] - Researchers found significant differences in spatial gene expression between wild-type and Pax9-deficient mice, indicating Pax9's role in progenitor cell differentiation and maturation [6][7] - The analysis suggested that disrupted Wnt signaling due to loss of Pax9 expression affects proper bone formation, which could lead to potential therapeutic strategies for cleft palate anomalies [4][6]

New 5,000-plex gene panel increases plex by an order of magnitude and delivers industry-leading speed and throughput Key features of the new high-plex Xenium Prime 5K assay include: About 10x Genomics This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 as contained in Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, which fall under the "safe harbor" provisi ...

Core Viewpoint - Torex Gold Resources Inc. has outlined a multi-year exploration strategy for its Morelos Property, aiming to enhance mineral resources, achieve new discoveries, and extend the mine life beyond 2033 to ensure stable production and cash flow [2][3][6]. Exploration Strategy Overview - The Morelos Property spans 29,000 hectares within the Guerrero Gold Belt, featuring the ELG Mine Complex and Media Luna Project. The company has invested an average of $31 million annually in drilling and resource expansion since 2021, with a budget of $30 million for 2024 [6][7]. - The exploration strategy aims to maintain over 450,000 gold equivalent ounces (oz AuEq) of annual production beyond 2027 and to make at least one new discovery in the coming years [7][8]. Target Areas - The exploration strategy focuses on three main areas: 1. Extending the mine life of ELG Underground and Media Luna through infill and near-mine step-out drilling [7]. 2. Expanding resources within the Media Luna Cluster, including Media Luna, EPO, Media Luna West, Media Luna East, and Todos Santos [7]. 3. Advancing new exploration targets such as El Naranjo, Atzcala, Esperanza, Querenque, Tecate, El Olvido, and Victoria [7][8]. Geological Understanding - The company has identified three dominant styles of mineralization at Morelos: skarn, intermediate sulphidation (IS), and carbonate replacement deposits (CRD). This evolving understanding supports the potential for new discoveries [8][25]. Exploration Pipeline - The exploration pipeline includes various stages from target selection to resource delineation. The company aims to advance each target based on economic potential and strategic objectives [9][10]. - The 2023 drilling program successfully expanded Measured & Indicated Resources by 570 thousand oz AuEq, leading to an increase in Proven & Probable Reserves by 280 thousand oz AuEq, extending the mine life of ELG Underground by two years through 2028 [11][12]. Regional Exploration - A budget of $3 million is allocated for regional exploration in 2024, with plans for 3,000 meters of intermediate drill testing at El Naranjo to delineate geological features [21][22]. - The company is also exploring potential extensions to structural corridors on the north side of the Balsas River, similar to those at the ELG deposit [22]. Longer-Dated Targets - Other promising targets include Querenque, Tecate, Esperanza, El Olvido, and Victoria, which will be evaluated and advanced as appropriate in the exploration pipeline over the coming years [24][48].

The Xenium Prime 5K assay, optimized for human and mouse species, is now available for preorder and is expected to ship next month. About 10x Genomics 10x Genomics is a life science technology company building products to accelerate the mastery of biology and advance human health. Our integrated solutions include instruments, consumables and software for single cell and spatial biology, which help academic and translational researchers and biopharmaceutical companies understand biological systems at a resol ...

Torex Gold Releases 2023 Responsible Gold Mining Report Report shines a spotlight on continued excellence in ESG performance and disclosure May 21, 2024 6:00 PM EDT | Source: Torex Gold Resources Inc. (All amounts expressed in U.S. dollars unless otherwise stated) Toronto, Ontario--(Newsfile Corp. - May 21, 2024) - Torex Gold Resources Inc. (the "Company" or "Torex") (TSX: TXG) today released its 2023 Responsible Gold Mining Report (the "Report") titled At the Heart of Who we Are, the Company's ninth annual ...

Have you evaluated the performance of 10x Genomics' (TXG) international operations for the quarter ending March 2024? Given the extensive global presence of this life science technology company, analyzing the patterns in international revenues is crucial for understanding its financial strength and potential for growth.The global economy today is deeply interlinked, making a company's engagement with international markets a critical factor in determining its financial success and growth path. It has become ...

10x Genomics, Inc. (NASDAQ:TXG) Q1 2024 Earnings Conference Call April 30, 2024 4:30 PM ET Company Participants Cassie Corneau - Director of Investor Relations & Strategic Finance Serge Saxonov - Chief Executive Officer & Co-Founder Justin McAnear - Chief Financial Officer Conference Call Participants Mason Carrico - Stephens, Inc. Patrick Donnelly - Citigroup Daniel Arias - Stifel Financial Doug Schenkel - Wolfe Research Dan Brennan - TD Cowen Matt Larew - William Blair Matthew Sykes - Goldman Sachs Subbu ...

10x Genomics (TXG) reported $141.01 million in revenue for the quarter ended March 2024, representing a year-over-year increase of 5%. EPS of -$0.50 for the same period compares to -$0.44 a year ago.The reported revenue compares to the Zacks Consensus Estimate of $142.04 million, representing a surprise of -0.73%. The company delivered an EPS surprise of -8.70%, with the consensus EPS estimate being -$0.46.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- an ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _____________________ FORM 10-Q _____________________ (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ___________ to ___________ Commission File Number: 001-39035 10x Genomics, Inc. (Exact Name of R ...